Abstract
We have previously reported that phosphorylation of human urokinase on Ser138/303 abolishes its catalytic-independent motogen and proadhesive abilities, whereas receptor binding is not affected. Here we show that substitution of the two relevant serines with glutamic acid residues impairs the ability of urokinase to mobilize a variety of human and mouse cell lines as well as human primary T lymphocytes. Accordingly, urokinase receptor-dependent signaling, leading to cytoskeletal rearrangements and paxillin re-distribution, does not occur in MCF-7 breast carcinoma cells exposed to 'phosphorylation-like' urokinase. Unlike the wild-type form, di-substituted urokinase is unable to induce the physical association of urokinase receptor with alphavbeta5 vitronectin receptor, which is required for MCF-7 urokinase-dependent cell migration. Finally, the di-substituted variant fails to activate p55fgr, a member of the Src tyrosine kinase family, which mediates cell migration and adhesion of U937 myelomonocytic cells. In conclusion, the finding that specific amino acid substitutions strongly interfere with the ability of urokinase to stimulate cell migration, and the associated intracellular events uncover a novel way to regulate urokinase...Continue Reading
References
Jun 18, 1990·FEBS Letters·M R MastronicolaF Blasi
Dec 1, 1988·Experimental Cell Research·G FibbiM Del Rosso
Aug 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M P StoppelliR K Assoian
Apr 1, 1995·The Journal of Experimental Medicine·J BohuslavH Stockinger
Jun 9, 1995·Journal of Immunological Methods·A C AkdişS S Alkan
Sep 1, 1993·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·H T MyöhänenA Vaheri
Dec 22, 1995·The Journal of Biological Chemistry·C LiV Gurewich
May 3, 1996·The Journal of Biological Chemistry·M O De Nichilo, K M Yamada
May 1, 1996·European Journal of Biochemistry·V MagdolenO Wilhelm
Sep 1, 1996·The Journal of Cell Biology·J M LewisM A Schwartz
Nov 15, 1996·The Journal of Biological Chemistry·M YebraD A Cheresh
May 5, 1997·The Journal of Cell Biology·P FrancoM P Stoppelli
Jul 3, 1997·International Journal of Cancer. Journal International Du Cancer·P A AndreasenM J Duffy
Oct 23, 1997·Current Opinion in Cell Biology·H A Chapman
Jul 11, 1998·The Journal of Biological Chemistry·H TangD E Vaughan
Oct 9, 1998·The Journal of Biological Chemistry·P FrancoM P Stoppelli
Apr 6, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·R J TresslerS Rosenberg
Jun 5, 1999·The EMBO Journal·F ChiaradonnaM P Stoppelli
Aug 14, 1999·Science·F G Giancotti, E Ruoslahti
Apr 1, 2000·The Journal of Biological Chemistry·D I SimonH A Chapman
Jun 13, 2000·Advances in Experimental Medicine and Biology·V MagdolenM Schmitt
Jul 6, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Y GuoS A Rabbani
Jul 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·K MishimaH J Huang
Sep 9, 2000·Current Opinion in Cell Biology·L Ossowski, J A Aguirre-Ghiso
May 22, 2001·Oncogene·B DegryseF Blasi
Jun 27, 2001·The Journal of Cell Biology·C M LaukaitisA F Horwitz
Citations
Mar 26, 2008·The Journal of Biological Chemistry·Thore HilligNiels Behrendt
Apr 23, 2004·Biological Chemistry·Niels Behrendt
Oct 11, 2008·International Journal of Cancer. Journal International Du Cancer·Immacolata VoccaMaria Patrizia Stoppelli
Apr 15, 2015·Frontiers in Immunology·Malcolm Finlayson
Nov 26, 2002·International Journal of Cancer. Journal International Du Cancer·Immacolata SilvestriMaria Vincenza Carriero
May 4, 2005·The Journal of Biological Chemistry·Lucia GargiuloMaria V Carriero
Mar 23, 2013·Chembiochem : a European Journal of Chemical Biology·Paola FrancoMaria Patrizia Stoppelli
Aug 3, 2006·Journal of Cell Science·Paola FrancoMaria P Stoppelli